Animal Diseases Research Site Logo
ARS Home About Us Helptop nav spacerContact Us En Espanoltop nav spacer
Printable VersionPrintable Version     E-mail this pageE-mail this page
Agricultural Research Service United States Department of Agriculture
Search
  Advanced Search
 
Programs and Projects
Subjects of Investigation
 

Research Project: TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES: THE ROLE OF GENETICS, STRAIN VARIATION, AND ENVIRONMENTAL CONTAMINATION IN DISEASE CONTROL

Location: Animal Diseases Research

Title: Cytokine antibody array analysis in brain and periphery of scrapie-infected Tg338 mice

Authors
item Newsom, Denise -
item Liggitt, H -
item O'Rourke, Katherine
item Zhuang, Dongyue
item Schneider, David
item Harrington, Robert -

Submitted to: Comparative Immunology Microbiology and Infectious Diseases
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: June 28, 2011
Publication Date: September 1, 2011
Citation: Newsom, D.M., Liggitt, H.D., Orourke, K.I., Zhuang, D., Schneider, D.A., Harrington, R.D. 2011. Cytokine antibody array analysis in brain and periphery of scrapie-infected Tg338 mice. Comparative Immunology Microbiology and Infectious Diseases. 34(5):387-97.

Interpretive Summary: Scrapie is a naturally occurring transmissible spongiform encephalopathy that affects sheep and goats. The way that these diseases progress are not fully understood. However, changes in the level of cytokines (molecules that communicate between cells) may be an important part of the process. Therefore, an assay that can simultaneously measure 62 cytokines was used to determined what changes may be present. It was found that four cytokines had significantly increased levels over time, and these cytokines recruit a key cell type that is involved in the disease. These findings point to important factors for additional study of scrapie to further our understanding of disease. Such studies may lead to discovery of targets for live animal diagnosis and treatment.

Technical Abstract: Scrapie is a naturally occurring transmissible spongiform encephalopathy (TSE) that affects sheep and goats. While a change in prion protein conformation has been established as an important aspect of disease, other aspects of TSE pathogenesis are not fully understood. The preset study used protein expression microarrays to determine if cytokine protein levels in the brain and periphery increase during the course of scrapie infection, and if such changes correlated with clinical signs and histopathology. 62 cytokine proteins were screened in the Tg338 murine model of scrapie infection. For most cytokines, the pattern of expression in the brain, spleen, serum and mesenteric lymph node consisted of an increase in expression over control animals at the first time point studies (100 days p.i.), with these levels dipping slightly at the intermediate time point tested (160 days p.i.), only to increase again at the end stage of infection (>190 days p.i.) Four of the 62 cytokines were found to be increased over controls at all points of infection in both the brain and serum: eotaxin-2, IL-4, lymphotactin and SDF-1A. Further statistical analysis was done on these 4 cytokines. The levels of eotaxin and IL-4 were increased in serum and all four cytokines were increased in brain; these changes were significantly greater than the control values at all time points of infection. These 4 cytokines are involved in dendritic cell recruitment and expression, and therefore this information along with the general pattern of cytokine protein expression revealed in all examined tissues could aid in discerning the pathogenesis of scrapie-induced disease and other TSEs. This finding could also be important for future studies aiming to identify antemortem biomarkers for scrapie infection.

   

 
Project Team
Knowles, Donald - Don
White, Stephen
Schneider, David
 
Publications
   Publications
 
Related National Programs
  Animal Health (103)
 
 
Last Modified: 05/22/2013
ARS Home | USDA.gov | Site Map | Policies and Links 
FOIA | Accessibility Statement | Privacy Policy | Nondiscrimination Statement | Information Quality | USA.gov | White House